ArticleCancer medicine2023

Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.